Teva (TEVA) director receives 7,242 restricted share units as equity grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Lichtenstein Chen reported acquisition or exercise transactions in this Form 4 filing.
TEVA PHARMACEUTICAL INDUSTRIES LTD director Lichtenstein Chen received a grant of 7,242 Restricted Share Units (RSUs). These RSUs were granted on May 28, 2026 and are scheduled to vest on May 28, 2027, functioning as part of equity-based compensation.
Each RSU represents a contingent right to receive, at settlement, either one ordinary share or the cash value of one ordinary share, at the option of the Human Resources and Compensation Committee. The ordinary shares may be represented by American Depositary Shares, with each ADS currently representing one ordinary share.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Lichtenstein Chen
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Share Units | 7,242 | $0.00 | -- |
Holdings After Transaction:
Restricted Share Units — 7,242 shares (Direct, null)
Footnotes (1)
- Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on May 28, 2026 and vest on May 28, 2027. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Key Figures
RSUs granted: 7,242 units
Grant date: May 28, 2026
Vesting date: May 28, 2027
+2 more
5 metrics
RSUs granted
7,242 units
Restricted Share Units granted May 28, 2026
Grant date
May 28, 2026
RSU award date
Vesting date
May 28, 2027
Scheduled RSU vesting
Underlying shares
7,242 ordinary shares
Shares underlying granted RSUs
Exercise/settlement price
$0.00 per unit
RSU grant has no purchase price
Key Terms
Restricted Share Units, contingent right, ordinary share, American Depositary Shares, +1 more
5 terms
contingent right financial
"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or..."
equity-based compensation financial
"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."
Equity-based compensation is pay given to employees or contractors in the form of company ownership—such as stock, stock options, or restricted shares—instead of or in addition to cash. It matters to investors because it aligns workers’ interests with shareholders (like giving employees a slice of the company pie), but can also dilute existing owners and appears as a real cost on financial statements, affecting earnings and share value.
FAQ
What did TEVA (TEVA) director Lichtenstein Chen report in this Form 4?
The Form 4 reports a grant of 7,242 Restricted Share Units to director Lichtenstein Chen. These RSUs are equity-based compensation, not an open-market stock purchase or sale, and increase the director’s potential future ownership if they vest and settle in ordinary shares.
What is the ownership position after this TEVA (TEVA) RSU grant?
After the grant, the Form 4 shows 7,242 Restricted Share Units attributed to the director in this award. These RSUs are held directly and represent potential future ordinary shares or cash, depending on vesting and the form of settlement chosen at that time.